These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 23147804
1. Time-frequency analysis of transient-evoked otoacoustic emissions in children exposed to carboplatin chemotherapy. Bhagat S, Bass J, Qaddoumi I, Brennan R, Wilson M, Wu J, Galindo CR, Paglialonga A, Tognola G. Audiol Neurootol; 2013; 18(2):71-82. PubMed ID: 23147804 [Abstract] [Full Text] [Related]
2. Monitoring carboplatin ototoxicity with distortion-product otoacoustic emissions in children with retinoblastoma. Bhagat SP, Bass JK, White ST, Qaddoumi I, Wilson MW, Wu J, Rodriguez-Galindo C. Int J Pediatr Otorhinolaryngol; 2010 Oct; 74(10):1156-63. PubMed ID: 20667604 [Abstract] [Full Text] [Related]
5. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia]. Lisowska G, Namysłowski G, Hajduk A, Polok A, Tomaszewska R, Misiołek M. Otolaryngol Pol; 2006 Oct; 60(3):415-20. PubMed ID: 16989457 [Abstract] [Full Text] [Related]
6. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)]. Hoth S. Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275 [Abstract] [Full Text] [Related]
7. A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy. Lambert MP, Shields C, Meadows AT. Pediatr Blood Cancer; 2008 Feb; 50(2):223-6. PubMed ID: 17278120 [Abstract] [Full Text] [Related]
12. [Hearing loss caused by high dose carboplatin therapy]. Lautermann J, Adamczyk M, ten Cate WJ, Kloke O. Laryngorhinootologie; 1998 Feb; 77(2):82-4. PubMed ID: 9555700 [Abstract] [Full Text] [Related]
13. Cochlear active mechanisms in young normal-hearing subjects affected by Williams syndrome: time-frequency analysis of otoacoustic emissions. Paglialonga A, Barozzi S, Brambilla D, Soi D, Cesarani A, Gagliardi C, Comiotto E, Spreafico E, Tognola G. Hear Res; 2011 Feb; 272(1-2):157-67. PubMed ID: 20969939 [Abstract] [Full Text] [Related]
14. Long-term audiologic follow-up of carboplatin-treated children with retinoblastoma. Geurtsen ML, Kors WA, Moll AC, Smits C. Ophthalmic Genet; 2017 Feb; 38(1):74-78. PubMed ID: 27050825 [Abstract] [Full Text] [Related]
16. Distortion product otoacoustic emissions: an objective technique for the screening of hearing loss in children treated with platin derivatives. Dhooge I, Dhooge C, Geukens S, De Clerck B, De Vel E, Vinck BM. Int J Audiol; 2006 Jun; 45(6):337-43. PubMed ID: 16777780 [Abstract] [Full Text] [Related]
17. Detection of cisplatin-induced ototoxicity with transient evoked otoacoustic emission test before pure tone audiometer. Yilmaz S, Oktem F, Karaman E. Eur Arch Otorhinolaryngol; 2010 Jul; 267(7):1041-4. PubMed ID: 19946777 [Abstract] [Full Text] [Related]
18. Carboplatin-associated ototoxicity in children with retinoblastoma. Qaddoumi I, Bass JK, Wu J, Billups CA, Wozniak AW, Merchant TE, Haik BG, Wilson MW, Rodriguez-Galindo C. J Clin Oncol; 2012 Apr 01; 30(10):1034-41. PubMed ID: 22370329 [Abstract] [Full Text] [Related]
19. A role for otoacoustic emissions in screening for hearing impairment and middle ear disorders in school-age children. Nozza RJ, Sabo DL, Mandel EM. Ear Hear; 1997 Jun 01; 18(3):227-39. PubMed ID: 9201458 [Abstract] [Full Text] [Related]